Quarterly report pursuant to Section 13 or 15(d)

Net Income Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Income Loss Per Share (Details)

v3.21.1
Net Income Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Income Loss Per Share (Details) - Class A Common Stock - shares
shares in Thousands
 3 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Total weighted-average anti-dilutive common stock equivalents 339,609 355,106
Convertible Preferred Stock    
Total weighted-average anti-dilutive common stock equivalents 278,940 282,108
Unvested RSUs    
Total weighted-average anti-dilutive common stock equivalents 36,184 26,670
Outstanding Stock Options    
Total weighted-average anti-dilutive common stock equivalents 22,205 46,039
Shares Subject to Repurchase from RSAs and Early Exercised Stock Options    
Total weighted-average anti-dilutive common stock equivalents 2,280 289